Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 3, 2003, Pages 277-287

  Segel, George B ^a   Woodlock, Timothy J ^a   Xu, Jia ^a   Li, Liqiong ^a   Felgar, Raymond E ^a   Ryan, Daniel H ^a   Lichtman, Marshall A ^a   Wang, Nancy ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; CD69 ANTIGEN; DUAL SPECIFICITY PHOSPHATASE 2; EARLY GROWTH RESPONSE FACTOR 1; HEAT SHOCK PROTEIN 60; MESSENGER RNA; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATASE; POKEWEED MITOGEN; PROTEIN BCL 2; PROTEIN KINASE C; PROTEIN STRA6; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA MICROARRAY; ENZYME SPECIFICITY; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNOFLUORESCENCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; UPREGULATION;

PHYTOLACCACEAE;

EID: 0038638902     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00035-4     Document Type: Article

References (75)

1. Kipps T.J. Chronic lymphocyte leukemia and related diseases. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., Seligsohn U. Williams Hematology. sixth ed. 2001;1163-1194 McGraw-Hill Book Co, New York.
2. Pangalis G.A., Angelopoulou M.K., Vassilakopoulos T.P., Siakantaris M.P., Kittas C. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstron's macroglobulinemia a clinical, morphologic and biologic spectrum of similar disorders . Semin. Hematol. 36:1999;104-114.
3. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 99:2002;4087-4093.
4. Totterman T.H., Nilsson K., Sandstrom C. Phorbol ester-induced differentiation of chronic lymphocytic leukemia cells. Nature. 288:1980;176-178.
5. Carlsson M., Totterman T.H., Matsson P., Nilsson K. Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA. Blood. 71:1988;415-421.
6. Ashendel C.L. The phorbol ester receptor a phospholipid-regulated protein kinase . Biochem. Biophys. Acta. 822:1985;219-242.
7. Okamura J., Letarte M., Stein L.D., Sigal N.H., Gelfand E.W. Modulation of chronic lymphocytic leukemia cells by phorbol ester increase in Ia expression, IgM secretion and MLR stimulatory capacity . J. Immunol. 128:1982;2276-2280.
8. Gordon J., Mellstedt H., Aman P., Biberfeld P., Klein G. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester induction of IgM secretion and changes in the expression of B cell associated surface antigens . J. Immunol. 132:1984;541-547.
9. Woodlock T.J., Segel G.B., Lichtman M.A. Phorbol ester restores L-system amino acid transport of B lymphocytes in chronic lymphocytic leukemia. J. Clin. Invest. 81:1988;32-38.
10. Woodlock T.J., Chen Y., Young D.A., Bethlendy G., Lichtman M.A., Segel G.B. Association of HSP60-like proteins with the L-system amino acid transporter. Arch. Biochem. Biophys. 338:1997;50-56.
11. Woodlock T.J., Bethlendy G., Segel G.B. Prohibitin expression is increased in phorbol ester-treated chronic leukemic B lymphocytes. Blood Cells Mol. Dis. 27:2001;27-34.
12. Kharbanda S., Nakamura T., Stone R., Hass R., Bernstein S., Datta R., et al. Expression of early growth response 1 and 2 zinc finger genes during induction of monocyte differentiation. J. Clin. Invest. 88:1991;571-577.
13. Decker E.L., Skerka C., Zipfel P.F. The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells. J. Biol. Chem. 273:1998;26923-26930.
14. Halvorson L.M., Kaiser U.B., Chin W.W. The protein kinase C system acts through the early growth response protein 1 to increase LH beta gene expression in synergy with steroidogenic factor-1. Mol. Endocrinol. 13:1999;106-116.
15. Chauhan D., Kharbanda S.M., Uchiyama H., Urashima M., Anderson K.C. Activation of pp90rsk and early growth response-1 gene expression by pokeweed mitogen in human B cells. Leuk. Res. 19:1995;337-344.
16. Dinkel A., Warnatz K., Ledermann B., Rolink A., Zipfel P.F., Burki K., et al. The transcription factor early growth response 1 (EGR-1) advances differentiation of pre-B and immature B cells. J. Exp. Med. 188:1998;2215-2224.
17. Gopalbhai K., Meloche S. Repression of mitogen-activated protein kinases ERK 1/ERK 2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. J. Cell Physiol. 174:1998;35-47.
18. Ward Y., Gupta S., Jensen P., Wartmann M., Davis R.J., Kelly K. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature. 367:1994;651-654.
19. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
20. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H., et al. Identification of a candidate tumour suppression gene, MMAC 1, at chromosome 10q 23.3 that is mutated in multiple advanced cancers. Nature Genet. 15:1997;356-362.
21. Swat W., Dessing M., vonBoehmer H., Kisielow P. CD69 expression during selection and maturation of CD4 + 8 + thymocytes. Euro. J. Immunol. 23:1993;739-746.
22. Bezouska K., Nepovim A., Horvath O., Pospisil M., Hamann J., Feizi T. CD69 antigen of human lymphocytes in a calcium-dependent carbohydrate-binding protein. Biochem. Biophys. Res. Commun. 208:1995;68-74.
23. Hare K.J., Tenkinson E.J., Anderson G. CD69 expression discriminates MHC-dependent and independent stages of thymocyte positive selection. J. Immunol. 162:1999;3978-3983.
24. Bohmann D., Bos T.J., Admon A., Nishimura T., Vogt P.K., Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 238:1987;1386-1392.
25. Rauscher F.J. III, Cohen D.R., Cavran T., Bos T.J., Vogt P.K., Bohmann D., et al. Fos-associated protein p39 is the product of the jun proto-oncogene. Science. 240:1988;1010-1016.
26. Gignac S.M., Buschie M., Pettit G.R., Hoffbrand A.V., Drexler H.F. Expression of proto-oncogene c-jun during differentiation of B chronic lymphocytic leukemia. Leukemia. 4:1990;441-444.
27. Sassone-Corsi P., Ransone L.J., Lamph W.W., Verma I.M. Direct interaction between fos and jun nuclear oncoproteins role of the "leucine zipper" domain . Nature. 336:1988;692-695.
28. Schuermann M., Neuberg M., Hunter J.B., Jenuwein T., Ryseck R.P., Bravo R., et al. The leucine repeat motif in fos protein mediates complex formation with jun/AP-1 and is required for transformation. Cell. 56:1989;507-516.
29. Szeto W., Jiang W., Tice D.A., Rubinfeld B., Hollingshead P.G., Fong S.E., et al. Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res. 61:2001;4197-4205.
30. Chazaud C., Bouillet P., Oulad-Abdelghani M., Dolle P. Restricted expression of a novel retinoic acid responsive gene during limb bud dorsoventral patterning and endochondral ossification. Dev. Genet. 19:1996;66-73.
31. Blum S., Forsdyke R.E., Forsdyke D.R. Three human homologs of a murine gene encoding an inhibitor of stem cell proliferation. DNA Cell Biol. 9:1990;589-602.
32. Heximer S.P., Forsdyke D.R. A human putative lymphocyte Go/Gl switch gene homologous to a rodent gene encoding a zinc-binding potential transcription factor. DNA Cell Biol. 12:1993;73-88.
33. Schraven B., Schoenhaut D., Bruyns E., Koretzky G., Eckerskorn C., Wallich R., et al. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J. Biol. Chem. 269:1994;29102-29111.
34. Sica G.L., Zhu G., Tomada K., Liu D., Ni J., Chen L. RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-kappa B. Blood. 97:2001;2702-2707.
35. Parge H.E., Arvai A.S., Murtari D.J., Reed S.I., Tainer T.A. Human CksHs2 atomic structure a role for its hexameric assembly in cell cycle control . Science. 262:1993;387-395.
36. Nishihira J., Fujinaga M., Kuriyama T., Suzuki M., Sagimoto H., Nakagawa A., et al. Molecular cloning of human D-dopachrome tautomerase cDNA N-terminal proline is essential for enzyme activation . Biochem. Biophys. Res. Commun. 243:1998;538-544.
37. Tedder T.F., Streuli M., Schlossman S.F., Saito H. Isolation and structure of a cDNA encoding the B1 (CD20) cell surface antigen of human B lymphocytes. Proc. Natl. Acad. Sci. USA. 85:1988;208-212.
38. Golay J., Facchinetti V., Ying G., Introna M. The A-myb transcription factor in neoplastic and normal B cells. Leuk. Lymph. 26:1997;271-279.
39. Chu W., Burns D.K., Swerlick R.A., Presky D.H. Identification and characterization of a novel cytokine-inductible nuclear protein from human endothelial cells. J. Biol. Chem. 270:1995;10236-10245.
40. Durick K., Gill G.N., Taylor S.S. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mol. Cell. Biol. 18:1998;2298-2308.
41. Rasola A., Galietta L.J., Barone V., Romeo G., Bagnasco S. Molecular cloning and functional characterization of a GABA/betaine transporter from human kidney. FEBS Lett. 373:1995;229-233.
42. Drexler H.G., Janssen W.G., Brenner M.K., Hoffbrandt A.V., Bartram C.R. Rapid expression of proto-oncogenes c-fos and c-myc in B chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore. Blood. 73:1989;1656-1663.
43. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273:1998;23629-23632.
44. Broer S., Broer A., Hamprecht B. Expression of the surface antigen 4F2hc affects system L-like neutral amino acid transport activity in mammalian cells. Biochem. J. 324:1997;535-541.
45. Devore J., Peck R. Statistics The Exploration and Analysis of Data . 1986;117-120 West Publishing Co, St. Paul, MN.
46. Kitamura H., Kanehira K., Okita K., Morimatsu M., Saito M. MAIL, a novel nuclear 1 kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett. 485:2000;53-56.
47. Carballo E., Colomer D., Vives-Corrons J.L., Blacksheer P.J., Gil J. Characterization and purification of a protein kinase C substrate in human B cells. Identification as lymphocyte-specific protein 1 (LSP1). J. Immunol. 156:1996;1709-1713.
48. Forbes I.J., Zalewski P.D., Giannakis C., Cowled P.A. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198:1992;367-372.
49. Jabbar S.A., Hoffbrand A.V., Wickremasinghe R.G. Defects in signal transduction pathways in chronic B lymphocytic leukemia cells. Leuk. Lymphoma. 18:1995;163-170.
50. Ning Z.Q., Hirose T., Deed R., Newton J., Murphy J.J., Norton J.D. Early response gene signaling in bryostatin-stimulated primary B chronic lymphocytic leukemia cells in vitro. Biochem. J. 319:1996;59-65.
51. Schuh K., Avots A., Tony H.P., Serfling E., Kneitz C. Nuclear NF-AT-p is a hallmark of unstimulated B cells from B CLL patients. Leuk. Lymph. 23:1996;583-592.
52. Murphy J.J., Norton J.D. Phorbol ester induction of early response gene expression in lymphocytic leukemia and normal human B cells. Leuk. Res. 17:1993;657-662.
53. Osorio L.M., Jondal M., Aguilar-Santelises M. Regulation of B CLL apoptosis through membrane receptors and BCL2 family proteins. Leuk Lymphoma. 30:1998;247-256.
54. Niewiadomska H., Mirowski M., Kulczycka D., Najder M., Balcerczak E., Blonski J.Z. Some oncogene and tumor suppressor gene protein products expression in B cell chronic lymphocytic leukaemia. Cytobiology. 103:2000;159-168.
55. Aviram A., Radizedeh E., Zimra Y., Yeshoron M., Marmelstein M., Shaklei M., et al. Expression of bcl2 and bax in cells associated from B chronic lymphocytic leukemia patients at different stages of the disease. Eur. J. Haematol. 64:2000;80-84.
56. Pasqualucci L., Neri A., Baldini L., Dalla-Favera R., Migliazza A. BCL6 mutations are associated with immunoglobulin variable heavy chain mutations in B cell chronic lymphocytic leukemia. Cancer Res. 60:2000;5644-5648.
57. Sanchez P., de Torres Zabala M., Grant M. AtB1-1, a plant homologue of Bax inhibitor 1, suppresses Bax-induced cell death in yeast and is rapidly upregulated during wounding and pathogen challenge. Plant J. 21:2000;393-399.
58. Lagneaux L., Delforge A., Carlier S., Massy M., Bernier M., Bron D. Early induction of apoptosis in B chronic lymphocytic leukemia cells by hydroxychloroquine activation of caspase-3 and no protection by survival factors . Br. J. Haematol. 11:2001;344-352.
59. Meinhardt G., Roth J., Hass R. Activation of protein kinase C relays distinct signaling pathways in the same cell type differentiation and caspase-mediated apoptosis . Cell Death Differ. 7:2000;795-803.
60. Newcomb E.W., Rao L.S., Giknavorian S.S., Lee S.Y. Alterations of multiple tumor suppressor genes (p53)(17p13), p161NK4 (9p21), and DBM (13q14) in B cell chronic lymphocytic leukemia. Mol. Carcinogenesis. 14:1995;141-146.
61. Larkin A., Moran E., Alexander D., Clynes M. Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B cell leukaemias. Adv. Exp. Med. Biol. 457:1999;65-70.
62. Link D.C., Zuter M. The proto-oncogene c-fgr is expressed in normal mantle zone B lymphocytes and is developmentally regulated during myelomonocytic differentiation in vivo. Blood. 85:1995;472-479.
63. Tamaki T., Kanahura Y., Kuriu A., Ikeda H., Mitsui H., Yagura H., et al. Surface immunoglobulin-mediated signal transduction involves rapid phosphorylation and activation of the proto-oncogene product Raf-1 in human B cells. Cancer Res. 52:1992;566-570.
64. Woodlock T.J., Brown R., Mani M., Pompeo L., Hoffman H., Segel G.B., et al. Decreased L system amino acid transport and decreased gamma-glutamyl transpeptidase are independent processes in human chronic lymphocytic leukemia B lymphocytes. J. Cell Physiol. 145:1990;217-221.
65. Cartee L., Kucera G.L. Protein kinase C modulation and anticancer drug response. Cancer Invest. 18:2000;731-739.
66. Schena M., Larsson L.G., Gottardi D., Gaidano G., Carlsson M., Nilsson K., et al. Growth and differentiation associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood. 79:1992;2981-2989.
67. Murphy J.J., Norton J.D. Cell-type-specific early response gene expression during plasmactyoid differentiation of human B lymphocytic leukemia cells. Biochim. Biophys. Acta. 1049:1990;261-271.
68. Murphy J.J., Norton J.D. Coupling of early response gene expression to distinct regulatory pathways during α-interferon and phorbol ester-induced plasmactyoid differentiation of B chronic lymphocytic leukemia cells. FEBS Lett. 267:1990;242-244.
69. Gashler A., Sukhatme V.P. Early growth response protein (EGR-1). Prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50:1995;191-224.
70. Nair P., Muthukkumar S., Sells S.F., Han S.S., Sakhatmo V.P., Rangnekar V.M. Early growth response-1-dependent apoptosis is mediated by p53. J. Biolo. Chem. 272:1997;20131-20138.
71. Benschop R.J., Melamed D., Nemazee D., Cambier J.C. Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J. Exp. Med. 190:(6):1999;749-756.
72. Lazurica P., Sancho D., Torres M., Albella B., Marazuela M., Merino T., Bureren J.A., Martinez A.C., Sanchez-Madrid F. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood. 95:(7):2000;2312-2320.
73. Lishner M., Lalkin A., Klein A., Yarkoni S., Manor Y., Fejgin M., et al. The BCL-1, BCL-2, and BCL-3 oncogenes are involved in chronic lymphocytic leukemia. Detection by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 85:1995;118-123.
74. DeAngeli C., Gandini D., Cuneo A., Moretti S., Bigoni R., Roberti M.G., et al. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). Haematologica. 85:2000;913-921.
75. Gaidano G., Newcomb E.W., Gong J.Z., Tassi V., Neri A., Cortelezzi A., et al. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Amer. J. Pathol. 144:1994;1312-1319.